| Literature DB >> 32257755 |
Tadahito Yasuda1, Shigeki Nakagawa1, Katsunori Imai1, Hirohisa Okabe1, Hiromitsu Hayashi1, Yo-Ichi Yamashita1, Akira Chikamoto1, Kazutaka Ozono2, Yoshiki Mikami2, Hideo Baba1.
Abstract
A 54-year-old woman finished the treatment for chronic hepatitis C and achieved sustained virological response. She was identified with some tumor lesions at her liver during follow-up observation by ultrasonography. From contrast-enhanced computed tomography, there were four tumors at sub-segment 4/5, S5, S6, and S7. These lesions are slightly enhanced on arterial phase and washed out on delayed phase. Contrast-enhanced magnetic resonance imaging showed slight enhancement on arterial phase and defect on hepatocyte phase. Tumor markers including alpha fetoprotein, Des-Gamma-Carboxy Prothrombin, carcinoembryonic antigen, and carbohydrate antigen (CA19-9) were within normal range. The patient underwent partial hepatectomies of four tumors at S4/5, S5, S6, and S7. The patient was recovering well, so he discharged our hospital after 10 days from the operation. The histological assay of the resected specimen showed accumulation of lymphocyte with hyperplasia of lymphoid follicles accordant with tumor lesions. Immunohistochemical staining assay revealed a positive for CD3, CD20, CD10, and bcl-2. These findings eventually made a diagnosis of all four tumors as mucosa-associated lymphoid tissue lymphoma. Since previously published case reports and our case described nonspecific clinical features of this rare disease, it was difficult to get the certain diagnosis before histological confirmation and non-anatomical partial liver resection may be a good choice for both diagnosis and local therapy. © The Japan Society of Clinical Oncology 2020.Entities:
Keywords: Hepatic MALT lymphoma; Liver hepatectomy; Sustained virological response state of chronic hepatitis C
Year: 2020 PMID: 32257755 PMCID: PMC7109212 DOI: 10.1007/s13691-019-00397-z
Source DB: PubMed Journal: Int Cancer Conf J ISSN: 2192-3183